Hosted on MSN10h
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
cnbctv1819h
Lupin secures US FDA approval for generic version of Atrovent nasal spray
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Lupin share price in focus on approval from USFDA for nasal spray
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
Rolling Out17h
The surprising side effect Ozempic users never expected
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
emjreviews.com3d
NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
Daily3h
Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...